Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

After 96 weeks, 39% of patients offered a 50-mg dose of efruxifermin showed a clinically meaningful reduction in liver fibrosis, or scarring, without other symptoms of MASH getting worse ...

Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic dysfunction-associated steatohepatitis (MASH) analyses to send its stock up about 100%.

I've loved mashed potatoes since I was a kid, but it wasn't until well into adulthood that I realized how simple they are to make. After years of practice in the kitchen, here's my quick and easy ...

THE re-establishment of policing services in Tapini, Goilala in Central Province, is not just about law enforcement but also about instilling trust and working with communities says police minister ...

As part of the deal, PNG has agreed to tighten foreign investment screening and block economically unviable or high-risk projects. Papua New Guinea's government has promised not to push ahead with ...

At 96 weeks, efruxifermin, an engineered Fc-FGF21 fusion protein that mimics the endogenous activity of fibroblast growth factor 21 (FGF21), showed a 24% benefit on fibrosis reduction over placebo in ...

On February 13, 2025, the dub release of Solo Leveling season 2 episode 5 was delayed by one week, as announced by the series' official X account. The episode will be released alongside the next ...